Peritoneal dialysis (PD) solutions and peritoneal exchange: Acute and long-term effects

Nieren- und Hochdruckkrankheiten

Volumn 26, Issue SUPPL. 1, 1997, Pages

  Carlsson, O ^a   Kirchgessner, J ^b   Passlick Deetjen, J ^b   Rippe, A ^a   Rippe, B ^a  

^a LUND UNIVERSITY HOSPITAL   (Sweden)

^b FRESENIUS MEDICAL CARE   (Germany)

Author keywords

Bicarbonate; Peritoneal dialysis solutions; Peritoneal transport

Indexed keywords

BICARBONATE; PERITONEAL DIALYSIS FLUID;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; FLUID TRANSPORT; MALE; NONHUMAN; PERITONEAL DIALYSIS; PERITONEUM; RAT; ULTRAFILTRATION;

EID: 0030730681     PISSN: 03005224     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Carlsson O., E.R. Zakaria, B. Rippe: In vivo inhibition of transcellular water channels (Aquaporin-1) during acute peritoneal dialysis in rats. Am. J. Physiol. 277, H2254-H2262 (1996).
2. Chaimovitz C.: Peritoneal Dialysis. Nephrology Forum. Kidney Int. 45, 1226-1240 (1994).
3. Coles G.A., R. Gokal, C. Ogg, F. Jani et al.: A randomized controlled trial of a bicarbonate- and a bicarbonate/lactate-containing dialysis solution in CAPD. Perit. Dial. Int. 17, 48-51 (1997).
4. Comper W.D., T.C. Laurent: Physiological function of connective tissue polysaccharides. Physiol. Rew. 58, 255-315 (1978).
5. Dobbie J.W.: Durability of the peritoneal membrane. Biocompatibility of peritoneal dialysis solutions. Perit. Dial. Int. 7, S87-S92 (1995).
6. Dobbie J.W.: Morphology of the peritoneum in CAPD. Blood Purif. 7, 74-85 (1989).
7. Feriani M., D. Dissegna, G. LaGreca, J. Passlick-Deetjen: Short-term clinical study with bicarbonate-containing peritoneal dialysis solution. Perit. Dial. Int. 13, 296-301 (1993).
8. Lamb E.J., W.R. Cattell, A.J. Dawnay: In vitro formation of advanced glycation end-products in peritoneal dialysis fluid. Kidney Int. 47, 1768-1774 (1995).
9. Lieberek T., N. Topley, A. Jörres et al.: Peritoneal dialysis fluid inhibition of polymorphonuclear leukocyte respiratory burst activation is related to the lowering of intracellular pH. Nephron. 65, 260-265 (1993).
10. Medcalf J.F., K. Harris, J. Walls: Preserving the peritoneum in CAPD. Nephrol. Dial. Transpl. 12, 393-395 (1997).
11. Miller F.N., K.D. Nolph, I.G. Joshua, D.L. Wiegman, P.D. Harris, D.B. Aberdeen: Hyperosmolality, acetate and lactate: dilatory factors during peritoneal dialysis. Kidney Int. 29, 397-402 (1981).
12. Park M.S., O. Heimbürger, J. Waniewski, J. Werynski, A. Werynski, B.H. Lee, J. Bergström, B. Lindholm: The effect of dialysate acidity on peritoneal solute transport in the rat. Peril. Dial. Int. 15, 312-319 (1995).
13. Rippe B.: Pathophysiological description of the ultrastructural changes of the peritoneal membrane during long-term continuous ambulatory peritoneal dialysis. Blood Purif. 12, 132-136 (1994).
14. Rippe B., G. Stelin: Simulations of peritoneal solute transport during continuous ambulatory peritoneal dialysis (CAPD). Application of two-pore formalism. Kidney Int. 35, 1234-1244 (1989).
15. Rippe B., G. Stelin, B. Haraldsson: Computer simulations of peritoneal fluid transport in CAPD. Kidney Int. 40, 315-325 (1991).
16. Rippe B., O. Simonsen, A. Wieslander, C. Londgren: Clinical and physiological effects of a new, less toxic and less acidic fluid for peritoneal dialysis. Pent. Dial. Int. 17, 27-34 (1997).
17. Zakaria E.R., B. Rippe: Intraperitoneal fluid volume changes during peritoneal dialysis in the rat: Indicator dilution vs. volumetric measurements. Blood Purif. 13, 255-270 (1995).
18. Zakaria E.R., O. Carlsson, H. Sjunnesson, B. Rippe: The liver is not essential for solute transport during peritoneal dialysis. Kidney Int. 50, 298-303 (1996).